5-ALA guided surgery plus carmustine wafer implant and the Stupp regimen (radiotherapy and temozolomide) for the treatment of glioblastoma multiforme

Chirurgia

Volumn 24, Issue 6, 2011, Pages 353-356

  De'santi, M S ^a   Genovese, M ^a   Amoroso, E ^a   Manto, A ^a   Piucci, B ^a  

^a Umberto I Hospital   (Italy)

Author keywords

Aminolevulinic acid; Glioblastoma; Radiotherapy

Indexed keywords

AMINOLEVULINIC ACID; CARMUSTINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; GLIOBLASTOMA; HUMAN; OVERALL SURVIVAL;

EID: 84857580248     PISSN: 03949508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Davis FG, Kupelian V, Freels S, McCarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behaviour and major histology groups. J. Neurooncol 2001;3:152-8. (Pubitemid 33674106)
2. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. J Neurooncol 2002;4:278-99.
3. Stupp R, Mason WP, van den Bent MJ, Weiler M, Fisher B, Taphoorn MJ et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-96.
4. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001;95:190-8. (Pubitemid 32799739)
5. Laws ER, Shaffrey ME, Morris A, Anderson FA. Surgical management of intracranial gliomas - does radical resection improve outcome? Acta Neurochir Suppl 2003;85:47-53. (Pubitemid 38446150)
6. Sanai N, Berger MS.Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008;62:753-64.
7. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC et al. A phase III trial of local chemotherapy with biodegrad-able carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. J Neurooncol 2003;5:79-88. (Pubitemid 36422560)
8. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid.induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000;93:1003-12.
9. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ; ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392-401.
10. Novotny A, Stummer W. 5-aminolevulinic acid and the blood-brain barrier: a review. Med Laser Appl 2003,18:36-40. (Pubitemid 36505936)
11. Soffietti R, Rudà R, Trevisan E. New chemotherapy options fort the treatment of malignant glioma. Anticancer Drugs 2007;18:621-32. (Pubitemid 47343654)